Strategic Hemodynamic Support in High-Risk PCI: Translating Evidence into Practice with Sanjog Kalra, M.D.

In this on-demand session, Dr. Sanjog Kalra, Brompton Funds Professor of Interventional Cardiology at the University of Toronto and interventional cardiologist and cardiac critical care physician at the Peter Munk Cardiac Centre, presents a comprehensive, case-based framework for strategic hemodynamic support in high-risk PCI.

Drawing on over a decade of real-world experience and the latest clinical trial data, Dr. Kalra walks through how to identify the right patient, optimize hemodynamics before the procedure, execute a technically sound revascularization strategy, and manage the critical post-procedural period, arguing that each of these steps is inseparable from the others.

Dr. Kalra opens with a detailed case of a 64-year-old man with ischemic cardiomyopathy, complex multi-vessel coronary disease, and a prior intracranial hemorrhage precluding surgical bypass. He uses this case to illustrate how high-risk PCI is not simply a technical challenge, but a hemodynamic and strategic one as well.

Key webinar takeaways:

• How to identify and risk-stratify the high-risk PCI patient using clinical, anatomic, and hemodynamic criteria
• Why hemodynamic optimization before the procedure, not just during it, is essential to safe revascularization
• A practical framework for intra-procedural decision-making, including hemodynamic-guided assessment between vessel targets
• What loss of pulsatility episodes mean clinically and why they signal the limits of myocardial reserve
• How to interpret CHIP-BCIS3 in the context of your own practice, including the potential role of periprocedural optimization gaps, ICU care gaps, and post-procedural weaning strategy
• Why the CICU team's understanding of Impella management, such as weaning protocols, hemodynamic targets, and alarm recognition, may be as important as the procedure itself

Watch the webinar to learn about these takeaways and more.